Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)
Egypt · Delayed Price · Currency is EGP 365.00
+18.49 (5.34%)
At close: Oct 4, 2026
EGX:MPCI Ratios and Metrics
Market cap in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 8,304 | 1,684 | 505 | 174 | 78 | 150 | |
Market Cap Growth | 141.71% | 233.20% | 190.25% | 123.70% | -48.16% | 73.15% |
Enterprise Value | 7,963 | 1,090 | 220 | 403 | -31 | 123 |
Last Close Price | 365.00 | 69.65 | 26.25 | 8.72 | 3.90 | 7.52 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 16.00 | 3.33 | 2.64 | 1.93 | 1.05 | 3.59 |
PS Ratio | 4.96 | 1.12 | 0.58 | 0.26 | 0.14 | 0.29 |
PB Ratio | 11.70 | 2.19 | 3.39 | 1.66 | 2.13 | -3.93 |
P/TBV Ratio | 11.76 | 2.20 | 3.60 | 1.88 | 3.79 | - |
P/FCF Ratio | - | 25.65 | 3.18 | 3.75 | 3.31 | 107.03 |
P/OCF Ratio | - | 19.38 | 2.76 | 3.01 | 2.13 | 43.26 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 4.75 | 0.72 | 0.25 | 0.61 | - | 0.24 |
EV/EBITDA Ratio | 14.51 | 2.01 | 0.98 | 3.89 | - | 2.81 |
EV/EBIT Ratio | 15.08 | 2.09 | 1.04 | 4.21 | - | 3.61 |
EV/FCF Ratio | - | 16.61 | 1.39 | 8.67 | - | 87.71 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.12 | 0.12 | 1.19 | 0.13 | 0.13 | -0.14 |
Debt / EBITDA Ratio | 0.15 | 0.18 | 0.79 | 0.13 | 0.06 | 0.12 |
Debt / FCF Ratio | - | 1.45 | 1.12 | 0.29 | 0.20 | 3.82 |
Net Debt / Equity Ratio | -0.48 | -0.76 | -2.30 | -1.24 | -2.16 | 1.24 |
Net Debt / EBITDA Ratio | -0.62 | -1.08 | -1.53 | -1.26 | -1.03 | -1.08 |
Net Debt / FCF Ratio | 3.30 | -8.89 | -2.16 | -2.80 | -3.36 | -33.66 |
Asset Turnover | 1.15 | 1.11 | 0.87 | 0.99 | 1.11 | 1.28 |
Inventory Turnover | 2.01 | 2.34 | 2.40 | 2.29 | 2.41 | 2.60 |
Quick Ratio | 1.08 | 1.45 | 0.90 | 0.71 | 0.39 | 0.23 |
Current Ratio | 1.82 | 2.15 | 1.16 | 1.03 | 0.92 | 0.77 |
Return on Equity (ROE) | 95.06% | 109.89% | 150.74% | 127.74% | - | - |
Return on Assets (ROA) | 22.60% | 24.09% | 13.20% | 8.91% | 8.70% | 5.27% |
Return on Capital Employed (ROCE) | 68.40% | 61.90% | 81.00% | 88.10% | 180.70% | -95.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 6.25% | 30.00% | 37.88% | 51.93% | 95.17% | 27.84% |
FCF Yield | -1.24% | 3.90% | 31.42% | 26.70% | 30.25% | 0.93% |
Dividend Yield | 3.61% | 18.93% | 15.24% | 22.94% | - | - |
Payout Ratio | 37.97% | 5.05% | 6.35% | - | - | 0.60% |
Buyback Yield / Dilution | -304.44% | -304.44% | - | - | - | - |
Total Shareholder Return | -300.83% | -285.51% | 15.24% | 22.94% | - | - |